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Abstract
Protein-tyrosine phosphatase 1B (PTP1B) is a ubiquitously expressed PTP that is anchored to the endoplasmic reticulum
(ER). PTP1B dephosphorylates activated receptor tyrosine kinases after endocytosis, as they transit past the ER. However,
PTP1B also can access some plasma membrane (PM)-bound substrates at points of cell-cell contact. To explore how PTP1B
interacts with such substrates, we utilized quantitative cellular imaging approaches and mathematical modeling of protein
mobility. We find that the ER network comes in close proximity to the PM at apparently specialized regions of cell-cell
contact, enabling PTP1B to engage substrate(s) at these sites. Studies using PTP1B mutants show that the ER anchor plays
an important role in restricting its interactions with PM substrates mainly to regions of cell-cell contact. In addition,
treatment with PTP1B inhibitor leads to increased tyrosine phosphorylation of EphA2, a PTP1B substrate, specifically at
regions of cell-cell contact. Collectively, our results identify PM-proximal sub-regions of the ER as important sites of cellular
signaling regulation by PTP1B.
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Introduction
The ubiquitously expressed non-receptor protein-tyrosine
phosphatase (PTP1B) plays an important role in regulating diverse
cellular signaling pathways, including those initiated by receptor
tyrosine kinases (RTKs), cytokine receptors, integrins and cadher-
ins [1]. Major insights into the physiological role of PTP1B were
gained through the generation of knockout (KO) mice, which
showed that PTP1B is a critical regulator of insulin sensitivity and
energy balance in vivo [2,3,4,5]. However, other functions for
PTP1B have also been suggested, including roles in regulating cell-
matrix [6] and cell-cell [7,8,9] interactions. Given the salutary
metabolic effects of PTP1B deletion, it has emerged as a potential
target for anti-diabetic and anti-obesity drug development [10,11].
Consequently, it is important to understand its mechanism of
action in detail.
PTP1B is anchored to the cytosolic face of the endoplasmic
reticulum (ER) via a hydrophobic C-terminal targeting sequence
[12,13], which constrains its access to key substrates. Consistent
with this localization, PTP1B dephosphorylates the activated
epidermal growth factor receptor (EGFR), platelet-derived growth
factor receptor (PDGFR) and insulin receptor (IR) only after
endocytosis, as they transit past the ER [14,15,16]. PTP1B activity
also is spatially regulated in the cell, thus creating distinct
microenvironments that enable RTK signal propagation, followed
by signal termination [17]. Recently, PTP1B has been identified as
a potential regulator of RTK endocytosis. Eden et al. reported that
PTP1B-EGFR interaction occurs through direct membrane
contact between multivesicular bodies (MVB) and the ER, with
PTP1B activity promoting the sequestration of EGFR to MVB
internal vesicles [18]. Consistent with these findings, Stuible et al.
identified the endosomal protein STAM2, which regulates sorting
of activated RTKs for degradation, as a PTP1B substrate [19].
Collectively, these studies reveal that PTP1B is a major regulator
of RTK endocytosis and signaling.
Although activated RTKs gain access to PTP1B only after
endocytosis, PTP1B also can interact with some plasma mem-
brane (PM)-bound substrates [20,21]. For example, PTP1B targets
forming cell-matrix adhesion contacts and contributes to the
stabilization of focal adhesions. This process appears to involve
dynamic extension of the ER via a microtubule-dependent process
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24[6]. PTP1B also can access substrates at points of cell-cell contact
[7,8,9], although how these interactions are regulated remains
largely unexplored. In the present study, we assess the dynamics of
PTP1B mobility and investigate its spatial-temporal regulation of
signaling at regions of cell-cell contact. Through the combined use
of PTP1B mutants, advanced cell imaging and mathematical
modeling, we show that ER-anchored PTP1B can reach PM-
localized substrates, but only at regions of cell-cell contact. These
studies strongly suggest that the ER is structured and polarized
towards cell-cell junctions, and identify these PM-proximal sub-
regions of the ER as important sites of cellular signaling regulation
by PTP1B.
Results
PTP1B Substrate-trapping Mutant Localizes to Regions of
Cell-cell Contact
We transiently expressed green fluorescent protein (GFP)-tagged
wild type (WT) PTP1B and its ‘‘substrate-trapping’’ mutant
D181A (D/A), which retains substrate-binding but is catalytically
impaired [22], in PTP1B-null fibroblasts, and monitored their sub-
cellular localization using confocal microscopy (Fig. 1). Consistent
with previous reports [12,13], each localized to the ER network.
However, PTP1B D/A, but not PTP1B WT, also accumulated at
regions of cell-cell contact, labeled using anti-b catenin antibodies
(Fig. 1). Studies using another PM marker, Cherry-tagged G
protein-coupled receptor 43 (Grp43-Cherry), confirmed that
PTP1B D/A accumulated at regions of cell-cell contact in live
cells (Fig. 1, lower panel). Quantification of fluorescence intensity
showed that about 10–15% of total cellular PTP1B D/A was
found at cell-cell contacts. Similar findings were obtained using
Cos-7, MDCK, 293T cells and 3T3-L1 preadipocytes (data not
shown).
The ER Extends to Regions Proximal to PM at Cell-cell
Contacts
These observations raised the question of how an ER-bound
PTP might access substrates on or near the PM at regions of cell-
cell contact. In platelets, PTP1B can be cleaved by calpain to
release an active cytosolic fragment [23]. However, serial confocal
images of tissue culture cells expressing PTP1B D/A-GFP,
acquired at successive focal planes, revealed a ‘‘honeycomb’’
pattern at regions of cell-cell contact (Fig. S1a) which is
characteristic of the reticular structure of the ER and consistent
with its extension to these regions. Experiments in which PTP1B
D/A was co-expressed in MDCK cells with the general ER
marker, stress-related ER protein (SREP), confirmed that the ER
extends out to the PM at regions of cell-cell contact (Fig. 2a,
arrows). Comparable results were obtained when PTP1B D/A was
co-expressed with a marker (Sec61) for rough ER (Fig. 2b).
Exposure of cells to pervanadate, which oxidizes the essential
cysteinyl residue found at the catalytic center of PTPs [24],
abolished the localization of PTP1B D/A at cell-cell contacts
without altering its ER localization (or that of PTP1B WT in the
ER) (Fig. S1b). The latter findings indicate that PTP1B D/A
enrichment at regions of cell-cell contact is mediated by
interactions with one or more substrate(s).
Electron microscopy using immunogold-coupled anti-human
PTP1B (FG6) antibodies revealed labeling of PTP1B D/A in the
ER, providing direct evidence that PTP1B resides in this
compartment (Fig. 2c, arrows, left image). Prominent labeling
also was detected at regions of cell-cell contact (Fig. 2c, right image
and inset), where four adjacent membranes were evident: two
inner ‘‘thick’’ membranes (arrowheads) corresponding to the PMs
of adjacent cells and two flanking ‘‘thinner’’ membranes (arrows),
corresponding to the ER. The few gold particles that appeared to
label the PM probably reflect the antigen-gold particle linker
distance: because PTP1B should be separated from the gold
particle by the distance of the antibody molecule in three
dimensions [25,26], the particle can lie directly over PTP1B or
up to 10 nm away [26]. No significant labeling was detected in
PTP1B-null fibroblasts (Fig. 2c), confirming the specificity of the
immunogold labeling. To ask whether the observed proximity of
ER to PM at regions of cell-cell contact is caused by PTP1B D/A
expression, we performed routine EM and high resolution cryo-
EM on vitreous sections from HeLa cells. These studies confirmed
that the ER is in close proximity to the PM at regions of cell-cell
contact even in the absence of PTP1B D/A (Fig. S2). Collectively,
these studies show that the ER is in close proximity to the PM at
regions of cell-cell contact and that ER-anchored PTP1B engages
substrate(s) at these locations.
PTP1B Mobility on ER Membranes
To determine how an ER-bound phosphatase accesses PM
substrate(s) at regions of cell-cell contact, we examined the
mobility of PTP1B fused to photoactivatable GFP (PhAc), which
can be used to mark a population of molecules in a region of
interest and track them over time in live cells [27]. PTP1B WT-
PhAc and PTP1B D/A-PhAc were transiently co-expressed in
PTP1B-null cells with the corresponding RFP-tagged PTP1B,
which served as a general ER marker and helped to identify
transfected cells. Prior to photoactivation, no significant fluores-
cence attributable to PTP1B-PhAc (excitation at 488 nm) was
detected (Fig. 3). Photoactivation (excitation at 413 nm) of selected
regions resulted in pools of PTP1B WT or PTP1B D/A that
became highly fluorescent upon excitation at 488 nm. Continuous
imaging of the photoactivated pools revealed rapid, non-
directional movement of PTP1B WT throughout the ER
(Fig. 3a), with fluorescence intensity increasing gradually at
regions distal from the photoactivation site (Fig. 3b; note intensity
gain in distal region marked ‘‘4’’). PTP1B D/A-PhAc (but not
PTP1B WT-PhAc) that was initially photoactivated in the ER
(away from sites of cell-cell contact) became detectable at regions
of cell-cell contact, indicating that the ER is contiguous with these
areas and is the source of PM-proximal PTP1B (Fig. 3c). By
contrast, PTP1B D/A that was photoactivated at regions of cell-
cell contact (rectangle) diffused away more slowly compared with
pools activated in the ER (Fig. 3d; see below for detailed discussion
of this apparent difference in speed). Thus, the movement of
PTP1B is consistent with non-directional diffusion throughout the
ER. Moreover, these studies show that the ER network is
continuous, but lies proximal to the PM only at regions of cell-
cell contact.
PTP1B Mobility is Affected by Transient Interactions
The photoactivation experiments were complemented with
fluorescence recovery after photobleaching (FRAP) studies
[28,29,30]. GFP-labeled PTP1B WT or PTP1B D/A, expressed
in randomly growing PTP1B-null cells, was photobleached
irreversibly at the ER (circular area, 4 mm diameter) or at regions
of cell-cell contact (rectangular area, 5 mm length/1 mm width),
and the recovery of fluorescence in the photobleached area,
caused by the diffusion of unbleached PTP1B, was monitored
(Fig. 4a). Diffusion and binding parameters were determined from
the acquired data by fitting the recoveries to an exact mathemat-
ical solution based on a simplified geometry (Fig. 4b and
mathematical modeling section in Methods). For assessing
intracellular diffusion, recoveries for each molecule were fit to a
PTP1B and ER-PM Signaling
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diffusion constant and the immobile fraction. The effective
diffusion constant measures the combined effects of actual
diffusion speed (cytoplasmic or along the ER, in the absence of
interactions), as well as any transient binding interactions that can
slow molecular mobility. The immobile fraction reflects the
fraction that does not recover (at least on the timescale of several
minutes). The fitted effective cytoplasmic diffusion constant (Deff)
of PTP1B WT was 0.23+0.01 mm
2/s with an immobile fraction of
0.12+0.02 (mean + S.E.M.; n=11 cells). This diffusion constant
was comparable to that of the closely related, ER-anchored
TCPTP (0.20+0.01 mm
2/s) which, however, had a statistically
insignificant immobile fraction (0.04+0.03; n=12) and other ER-
anchored proteins [31,32], but was significantly lower than the
predominantly cytosolic Src homology-containing tyrosine phos-
phatase 2 (SHP2) (1.0+0.1 mm
2/s with a statistically insignificant
immobile fraction of 0.04+0.03; n=9). The effective diffusion of
PTP1B D/A in the ER was three-fold lower than that of PTP1B
WT: 0.070+0.003 mm
2/s, with a highly significant immobile
fraction of 0.28+0.02 (n=13). This lower diffusion constant (due
to a slower turnover for the transient interactions) and higher
immobile fraction (indicating an increased amount of stable
Figure 1. PTP1B localizes to regions of cell-cell contact. Randomly growing PTP1B-null fibroblasts transiently expressing PTP1B WT-GFP or
PTP1B D/A-GFP were fixed and co-stained with b-catenin antibodies and DAPI (top and middle panels). The bottom panel shows fibroblasts co-
expressing PTP1B D/A-GFP and the plasma membrane marker Grp43-mCherry in live cells. Regions of cell-cell contact are indicated with arrows. Scale
bars correspond to 5 mm.
doi:10.1371/journal.pone.0036633.g001
PTP1B and ER-PM Signaling
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substrate(s) in the ER [15]. The slower, but still efficient recovery
of PTP1B D/A - on a timescale of 10 seconds - automatically sets a
lower limit on the dissociation rate for transient interactions of
roughlykoff§0:1 s
21 (a slower dissociation rate is irreconcilable
with the observed efficient recovery).
The recovery of PTP1B D/A fluorescence at regions of cell-cell
contact was even slower (Fig. 4a, b). The slower recovery might be
explained in a number of ways, including the peripheral location
of the FRAP region (replenishing proteins must on average
traverse a larger distance and can approach from only one
direction), the amount of PTP1B D/A that accumulates at regions
of cell-cell contact (see mathematical model and Fig. S3f), and/or
a slow off-rate from binding sites at regions of cell-cell contact. To
help differentiate between these possibilities, we fit the recoveries
to an exact mathematical solution that employed a simplified
rectangular geometry. This model implicitly accounts for revers-
ible binding of PTP1B to its substrate(s) in the ER by assuming the
same effective diffusion constant determined above from the
FRAP measurements for PTP1B D/A in the ER, but explicitly
accounts for enzyme-substrate binding (both transient and
immobilizing) of the accumulated fraction at the region of cell-
cell contact (see mathematical model). Estimation of the exact
immobile fraction at regions of cell-cell contact was hampered
Figure 2. The endoplasmic reticulum lies in close proximity to the plasma membrane at regions of cell-cell contact. (a) MDCK cells co-
expressing PTP1B D/A-mCherry and a general marker for the endoplasmic reticulum, stress-related ER protein (SREP-YFP); or (b) PTP1B D/A-mCherry
Sec61-YFP, a marker for the rough ER. Arrows indicate region of cell-cell contact. Scale bars correspond to 10 mm. (c) Immunogold electron
microscopy shows PTP1B D/A localization in the ER (arrows). No significant labeling was detected in PTP1B-null cells (left bottom image). Significant
immunogold labeling was also detected at regions of cell-cell contact (right image). The boxed area, which is magnified below, shows the region of
cell-cell contact that reveals labeling at the ER (arrows) proximal to the PM (arrowheads). Also see Fig. S2. Scale bars correspond to 0.2 mm.
doi:10.1371/journal.pone.0036633.g002
PTP1B and ER-PM Signaling
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photobleaching and cell movement (on timescales greater than one
minute). Models assuming no immobile fraction or up to 30%-
70% (depending on the cell) fit the data equally well (the fits shown
in Figs. 4b and S3e assume no immobile fraction). This
uncertainty concerning the exact immobile fraction did not,
Figure 3. Diffusive motion of photoactivated PTP1B on the ER. (a) PTP1B-null fibroblasts co-expressing PTP1B WT-PhAc (upper panel) and
PTP1B WT-RFP (lower panel) were photoactivated in the ER (region indicated with a circle), and the photoactivated pool was followed for the
indicated times. (b) Cells were photoactivated at a region of interest (marked ‘‘1’’), and PTP1B fluorescence intensity at this and distal regions (marked
‘‘2–4’’) was quantified. The lower panel represents the change in fluorescence ratio (WT-PhAc/WT-RFP) at the four highlighted regions over time. (c)
Cells co-expressing PTP1B D/A-PhAc and PTP1B D/A-RFP were photoactivated in the ER (circle). For each set of figures, the region in the boxed area of
the top panel is shown magnified in the lower panel, with an arrow indicating the PM-proximal ER at regions of cell-cell contact (note that the
adjacent cell is not transfected). (d) Cells co-expressing PTP1B D/A-PhAc and PTP1B D/A-RFP were photoactivated at regions of cell-cell contact
(rectangle), revealing slower mobility compared to PTP1B D/A in the ER. Scale bars correspond to 5 mm.
doi:10.1371/journal.pone.0036633.g003
PTP1B and ER-PM Signaling
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Assuming an approximate accumulated amount of roughly ten
percent based on the images, the model could be reduced to the
determination of two parameters: the dissociation rate (of the
transient interactions) and the cell size. Additionally, for most cells,
only a lower limit on the dissociation rate could be determined (for
all cells, the dissociation rates were consistent with
koff§0:085+0:006 s
21), implying that the recoveries were
limited only by the cell size (diffusion-limited recovery). The
average cell size determined solely from the model fits was 28 mm,
which is comparable to the observed cell sizes and demonstrates
the overall self-consistency of our model with the observed
properties of the cells. The roughly factor-of-two differences in
recovery speeds from cell to cell can easily be attributed to the
observed differences in cell size, though they could also arise from
slight differences in the amount of accumulation at the cell-cell
contact region. Interestingly, the required rapid turnover of
transient interactions at these cell-cell contact sites (,10 seconds),
and the fact that limits on the immobile fraction are compatible
with the actual immobile fractions observed in intracellular
regions, suggest that the affinity of PTP1B for its substrate(s) at
regions of cell-cell contact is likely similar to that at other locations
Figure 4. Assessment of PTP1B mobility using Fluorescence Recovery after Photobleaching. (a) PTP1B-null fibroblasts expressing PTP1B
WT-GFP (upper panel) were photobleached in the indicated regions at the ER (circle), and fluorescence recovery was monitored for up to a minute
(images are shown for the first 20 sec). Cells expressing PTP1B D/A-GFP (middle and lower panels) were photobleached either at the ER (circle) or at
regions of cell-cell contact (rectangle). Scale bars correspond to 5 mm. (b) Quantification of intracellular fluorescence recovery in multiple cells
expressing PTP1B WT, PTP1B D/A, TC PTP or SHP2 (see Fig. S2 a–d). Also shown is the fluorescence recovery of PTP1B D/A at regions of cell-cell
contact (see Fig. S3e). For each PTP, actual data points are presented in color, whereas solid black lines represent fits to our mathematical model. See
main text and Supplementary Materials for a detailed discussion of modeling and fitting.
doi:10.1371/journal.pone.0036633.g004
PTP1B and ER-PM Signaling
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therefore be completely accounted for by the geometry of the
bleaching and, in particular, the amount of accumulated PTP1B-
D/A at the cell-cell contact region. The observed accumulation of
PTP1B D/A is consistent with a higher concentration of PTP1B
substrates at these regions (or generally on the PM) as compared
with the distributed substrates found throughout the cellular
interior, but is specifically not due to tighter binding of PTP1B to
substrates found at regions of cell-cell contact.
PTP1B Recruitment to Regions of Cell-cell Contact
We next analyzed the dynamics of PTP localization at regions of
cell-cell contact in response to stimulation of the EGFR, an
established PTP1B substrate (Fig. 5a). Cos-7 cells were co-
transfected with PTP1B D/A-dHcRed and EGFR-GFP, and the
localization of the two proteins was monitored by confocal time-
lapse microscopy. Although the EGFR was expressed uniformly
on the cell surface, we observed accumulation of mutant PTP1B at
regions of cell-cell contacts (Fig. 5a, arrowheads) even in the
absence of EGF treatment. Stimulation with EGF led to rapid
recruitment of additional dHcRed-labeled PTP1B D/A to these
regions (Fig. 5a, arrowheads, 2, 10 min). Importantly, the rapid
EGF-induced PTP1B D/A recruitment to regions of cell-cell
contact was not paralleled by increased localization of the EGFR
in these regions, as ratiometric analyses showed increased PTP1B/
EGFR fluorescence ratios at regions of cell-cell contact in response
to EGF stimulation (Fig. 5a, white regions in PTP1B/EGFR ratio
images). The increased PTP1B/EGFR ratio at the PM was
observed only at regions of cell-cell contact, even though EGFR
concentration, and presumably the amount of tyrosyl phosphor-
ylated EGFR (also see below), was the same at both locations.
Quantification of PTP1B D/A localization at cell-cell contacts
(contacts), compared with PM regions not in contact with
neighboring cells (no contacts) in multiple cells, confirmed that
the ratio of PTP1B/EGFR fluorescence intensities was signifi-
cantly higher at regions of cell contact compared to other areas of
the cell membrane (Fig. 5b); this difference between the data sets
‘‘contacts’’ and ‘‘no contacts’’ was highly significant (p,0.001;
Kolmogorov-Smirnov test).
To determine whether ER localization of PTP1B facilitates its
ability to access substrates at regions of cell-cell contact, we
analyzed the localization of PTP1B D/A lacking its ER-targeting
domain (PTP1B D/A CD-mCitrine) in MDCK cells stimulated
with EGF for 5 minutes (Fig. 5c). Unlike full length PTP1B D/A,
PTP1B D/A CD-mCitrine was found in the cytosol and could
interact with substrates all over the PM, with no apparent
preference for substrates at regions of cell-cell contact. This result
provides further evidence that the density of PTP1B substrates is
similar at regions of cell-cell contact and the rest of the PM. We
then co-expressed PTP1B D/A CD-mCitrine with ER-bound
PTP1B D/A mCherry, and stimulated cells with EGF for 5
minutes. Consistent with our previous observations, the ER-bound
form of PTP1B D/A preferentially accessed the PM at regions of
cell-cell contact. On the other hand, the ER domain mutant
PTP1B (free), which is localized throughout the cell and at the cell
periphery, was actually displaced from regions of cell-cell contact
(Fig. 5d). We interpret these findings as indicating that the high
local density of ER-anchored PTP1B (which is confined to a two-
dimensional surface) can outcompete the freely diffusible (soluble)
catalytic domain-only mutant in regions where the ER and PM
are in close contact. Collectively, these data demonstrate that ER-
bound PTP1B can only reach its PM-localized substrates at
regions of close ER-PM contact, and indicate that the ER anchor
plays an important role in restricting PTP1B interactions with PM
substrates mainly to regions of cell-cell contact.
The ER is Polarized Towards Regions of Cell-cell Contact
The above findings indicate that the ER is specifically organized
and oriented towards regions of cell-cell contact, which raised the
possibility that PTP1B might play a role in this process.
Microtubules contribute to the formation and stabilization of the
ER network [33,34]. To destabilize the ER network, we disrupted
microtubules using nocodazole, and ER retraction at the
periphery and regions of cell-cell contact was monitored using
total internal reflection microscopy (TIRF) [35]. Cos-7 cells were
co-transfected with PTP1B WT-mCitrine and RFP-tagged TK-
Ras (a general PM marker to identify areas of cell-cell contact and
account for cell shape changes) [36]. Consistent with previous
reports [37], we observed ER collapse, specifically the loss of
peripheral tubular ER through its conversion into sheet-like
structures that retracted from the cell periphery, after nocodazole
treatment (Fig. 6a and Fig. S4a). The extent of ER reorganization
varied between experiments depending on cell confluence, cell
type and shape. Nevertheless, the ER always retracted from
peripheral regions but seemed to persist at regions of cell-cell
contact. In isolated cells expressing PTP1B D/A, the ER retracted
only partially after nocodazole treatment, with long stretches of
tubular ER still attached to the PM at sites of focal adhesion to the
glass coverslip (Fig. S4b).
These observations raised the possibility that, rather than (or in
addition to) the ER directing PTP1B towards substrates at points
of cell-cell contact, PTP1B interactions with substrates might help
polarize the ER towards these regions. We reasoned that if this
was the case, then outcompeting endogenous PTP1B for substrate
interactions by overexpressing PTP1B D/A CD should allow the
ER to retract from regions of cell-cell contact after nocodazole
treatment. PTP1B WT localization is not altered by PTP1B D/A
co-expression (Fig. S5). PTP1B D/A CD-mCitrine, monomeric
Teal fluorescent protein (mTFP)-tagged Calreticulin (ER marker),
RFP-tagged TK-Ras and EGFR were co-transfected into MDCK
and Cos-7 cells. After starvation, cells were stimulated with EGF
(100 ng/ml) for 5 minutes (to increase phosphorylation and
recruitment of PTP1B D/A CD to its substrates), and then cells
were treated with nocodazole. The ER retracted from peripheral
regions as observed before, but failed to retract from regions of
cell-cell contact (Fig. 6b). To assess whether the expression of
PTP1B D/A CD was high enough to compete for substrates with
the endogenous pool of PTP1B, we measured the absolute
concentration of ectopically expressed PTP1B D/A CD across
the cell by correlating the image intensity of cytoplasmic PTP1B
D/A CD to its concentration, as determined by fluorescence
correlation spectroscopy [38]. A linear fit to this correlation
enabled the estimation (by extrapolation) of PTP1B D/A CD
concentrations at any point in the cell. The maximal concentration
of PTP1B D/A CD was observed at regions of cell-cell contact and
was approximately 9 mM (Fig. 6b). In the immediate cytoplasmic
vicinity of these cell-cell contacts, the concentration of PTP1B D/
A CD remained in the mM regime, which is comparable to the KD
for PTP1B D/A-substrate interactions [17]. We therefore
conclude that over-expressed PTP1B D/A CD should efficiently
compete with endogenous PTP1B for substrates at the PM of cell-
cell contacts. However, endogenous PTP1B may have an
additional advantage, as it is anchored to the 2D ER, which
may give it a geometrical advantage in its search for substrates
(higher kon) over the cytosolic PTP1B D/A CD (invalidating
arguments based on the KD, which assumes a search in 3D). To
even overcome the high-local concentration of ER-bound PTP1B,
PTP1B and ER-PM Signaling
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the ER-targeting domain but fused to the C-terminal membrane
anchoring residues of K(B)Ras (TK-Ras) (hereafter referred to as
PTP1B D/A-RFP-TK). We reasoned that anchoring PTP1B D/A
to the PM should give it an enhanced geometric, and consequently
kinetic, advantage in substrate interaction over the endogenous
ER-bound enzyme. We then co-expressed PTP1B D/A-RFP-TK
with TFP-tagged calreticulin and unlabeled EGFR, and treated
Cos-7 cells with nocodazole as described before. Again, the ER did
not retract from regions of cell-cell contact compared with other
regions of the PM (Fig. 6c). Taken together, these findings clearly
indicate that PTP1B-substrate interactions do not by themselves
stabilize the polarization of the ER to regions of cell-cell contact.
Rather, intrinsic polarization of the ER towards points of cell-cell
contact likely directs PTP1B towards these regions.
Regulation of Signaling at Regions of Cell-cell Contact by
PTP1B
The above findings indicated that there is an orientation of the
ER towards regions of cell-cell contact, which raised the possibility
that PTP1B may play a significant role in the regulation of signaling
at these cites. To test this hypothesis, we determined the effects of
PTP1B inhibition on the phosphorylation of substrates found at
regions of cell-cell contact. Cos-7 cells were transfected with
mCherry-tagged EphA2, a RTK that is closely related to EphA3 (a
recently described substrate of PTP1B) [39]. Tyrosine phosphory-
lation was monitored using the co-transfected YFP fused to SH2
domain of pp60
src (dSH2-YFP) [40]. Cells were treated with an
allosteric PTP1B inhibitor (539741) [41], which exhibits higher
selectivity compared with active site inhibitors, and then monitored
by confocal time-lapse microscopy for 60 minutes. Before inhibitor
treatment, EphA2 showed typical membrane distribution of a
RTK, with occasional accumulation at regions of cell-cell contact
(Fig. 7a, b, panel ii). In addition, dSH2-YFP showed expression in
the nucleus, punctuate clusters surrounding the cell typical of focal
adhesions (Fig. 7a, panel iii), and in some cases at regions of cell-cell
contact (Fig. 7b, panel iii yellow arrowheads). Minimal spatial
overlap was observed between dSH2 and EphA2 prior to inhibitor
treatment, even at regions of cell-cell contact (Fig. 7a, b panel iv
cyan arrowheads). On the other hand, treatment with PTP1B
inhibitorfor1 hrled toextensiveincreaseinspatialoverlapbetween
dSH2andEphA2 especially at regionsofcell-cell contact (Fig.7a,b,
panel vii). The increased tyrosine phosphorylation of EphA2 upon
PTP1B inhibition suggests that EphA2 is a potential PTP1B
substrate at these sites. These findings reveal that the ER-bound
PTP1B, by virtue of the organization and polarization of ER
towards points of cell-cell contact, can access its potential substrates
and regulate their activity at these regions.
Discussion
One of the earliest discoveries about PTP1B was its localization
to the cytosolic surface of the ER [12,13]. This result was initially
quite surprising, because biochemical and genetic studies soon
established that PTP1B dephosphorylates several RTKs, including
the PDGF, EGF and insulin receptors [2,3,42,43,44]. We
subsequently provided an answer to this topological dilemma
with the finding that RTKs encounter PTP1B only after they are
endocytosed [14], a finding confirmed and extended by several
other groups [15,16,45]. Nevertheless, other work indicates that
PTP1B can access PM substrates at points of cell-cell contact [21].
These results raise an apparent paradox: why can PTP1B
dephosphorylate some substrates only after endocytosis, whereas
others can be targeted while at the PM? The results herein provide
a solution to this paradox and present a novel mechanism of how
ER-PM signaling at regions of cell-cell contact is regulated. This
regulation is important in that it is observed in different cell types,
including those that do and do not form tight junctions. Our
findings clearly demonstrate that interactions between the PM and
the ER are not ubiquitous, but rather are restricted to regions of
cell-cell contact. In these regions, the ER network appears to be
specifically organized and oriented such that it is juxtaposed to the
PM. An analogous mechanism might also account for PTP1B
interactions with substrates at cell-matrix contacts.
If we envision that the ER can reach the PM everywhere in a
stochastic, dynamic way, then the local concentration of substrates
should determine the amount of PTP1B D/A at regions of cell-cell
contact. Conceivably, substrate concentrations at regions of cell-
cell contact are higher than elsewhere in the PM, in which case a
critical amount of substrate(s) must be present to enable the ER-
bound phosphatase to access them while they are still localized to
the PM. Our photoactivation and FRAP studies show that PTP1B
D/A rapidly moves in and out of regions of cell-cell contact
(replenished by the ER pool), with a residence time of ,10 s
(Figs. 3, 4). These findings are consistent with the presence of a
large number of PTP1B binding sites, presumably representing
substrates in these regions. Nevertheless, when the EGFR is at the
same concentration in the PM and regions of cell-cell contact,
interaction (without prior endocytosis) occurs only at the latter
location (Fig. 5). Furthermore, expression of the soluble cytosolic
domain of PTP1B D/A does not result in a specific enrichment of
this protein to points of cell-cell contact after EGF stimulation;
rather, this protein labels the PM uniformly, thereby excluding the
possibility that substrate density alone dictates where PTP1B
interacts with substrates at the PM. Varying rates of endocytosis (at
cell-cell contacts versus other areas of the PM) also might account
for the differential ability of PTP1B to access substrates at the PM.
Arguing against this model, though, we previously blocked RTK
endocytosis using dominant negative dynamin, but were unable to
detect direct interaction between PTP1B and PM-bound RTKs
using fluorescence lifetime imaging microscopy (FLIM) [14].
Taken together, these findings strongly suggest that additional
factors are instrumental in enabling ER-bound PTP1B to access
substrates specifically at regions of cell-cell contact. These factors
are likely responsible for polarizing the ER towards regions of cell-
cell contact, thereby creating specialized zones of ER-PM
interaction at cell-cell contacts in which PTP1B (and conceivably,
other ER proteins) may access the PM.
Figure 5. Quantification of PTP1B recruitment to regions of cell-cell contact. (a) Cos-7 cells co-expressing PTP1B D/A-dHcRed and EGFR-
GFP were stimulated with EGF (100 ng/ml), and monitored by confocal time lapse microscopy. Ratio images (right panels) were generated by
dividing PTP1B D/A by EGFR fluorescence following image processing as described in Materials and Methods. Scale bars correspond to 10 mm. (b)
Distribution of PTP1B/EGFR intensity ratios in regions of cell-cell contact versus no contact (n=21 cells). The difference between the two data sets is
highly significant (p,0.001, Kolmogorov-Smirnov test). (c) Cells expressing mCitrine-tagged PTP1B D/A CD, shown at 5 min after EGF stimulation.
Note that this mutant form of PTP1B can access substrates along the entire PM (arrows). (d) Cells co-expressing mCitrine-tagged PTP1B DA CD and
mCherry-tagged PTP1B-D/A following EGF stimulation (5 min). Peripheral regions (regions without cell-cell contact) that show accumulation of
mCitrine-tagged PTP1B D/A CD are indicated by arrows, whereas regions where ER-anchored PTP1B excluded mCitrine-tagged PTP1B D/A CD are
indicated by arrowheads. Scale bars in (c) and (d) correspond to 20 mm.
doi:10.1371/journal.pone.0036633.g005
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PLoS ONE | www.plosone.org 10 May 2012 | Volume 7 | Issue 5 | e36633There are precedents for the existence of specific ER-PM
signaling compartments. Studies using S. cerevesiae indicate that
membrane curvature may help to define functionally distinct sub-
domains in the ER [46,47,48]. Whether an analogous mechanism
creates ER sub-domains near regions of cell-cell contact in
mammalian cells remains to be determined. In skeletal muscle,
the sarcoplasmic reticulum junctophilin proteins bind to PM
components to form junctional contacts [49]. A new paradigm for
ER-PM signaling has been proposed for the ER calcium sensor;
stromal interaction molecule 1 (STIM 1) [50]. After ER calcium
depletion,STIM 1 oligomerizes, and dueto enhanced avidity, binds
to and activates store-operated calcium channels at the PM
[50,51,52]. Ultrastructural studies reveal that upon calcium
depletion, STIM 1 induces the formation of cortical ER (cER),
whichiscomposedoflargesheetsthatarecloselyopposedtothePM
but still connected to conventional ER cisternae [53]. The distance
between cER and PM (on average 8.3 nm in Epon sections) is
comparable to the distance between ER-bound PTP1B and the PM
in our EM studies (Fig. 2). Moreover, mammalian STIM proteins
have a lysine-rich sequence that is similar to the yeast peripheral
protein Ist2 (a transmembrane protein that is localized to cER in
yeast). Remarkably, Ist2 enrichment at the cER of mammalian cells
directly modulates the formation and maintenance of this ER
subregion, and cER induction in vivo is dependent on microtubules
and the coat protein complex I (COPI) [54]. It will be important to
determine whether cER or some other higher order ER structure
promotes PTP1B interactions with substrates at cell-cell contacts.
The identity of these substrates and their contribution to cell-cell
signaling requires further investigation. Recent studies identified
interactions between PTP1B and EphA3 and revealed that the
interaction can occur at the plasma membrane at areas of EphA3/
ephrin-mediated cell-cell contact [39]. In the current study, we
report increased EphA2 tyrosine phosphorylation at regions of cell-
cell contact upon PTP1B inhibition, suggesting that EphA2 is
putative substrate of PTP1B at these sites. Other proteins known to
reside at cell-cell contacts, such as p120 catenin and Zonula
Occludens (ZO-1), are hyper-phosphorylated in PTP1B-null
fibroblasts, and represent additional candidate PTP1B substrates
in these regions [55]. Collectively, our studies suggest that the ER
plays a dynamic role in regulating signaling at regions of cell-cell
contact via PTP1B and highlight ER-PM interactions as an
emerging new paradigm in cellular signaling.
Materials and Methods
Cell Culture, Antibodies and Reagents
PTP1B-null fibroblasts (Haj et al. 2003), MDCK and Cos-7 cells
(both obtained from ATCC) were cultured on 35 mm glass bottom
culture dishes (MatTek Corporation) or 4-well Lab-Tek chambers
(Nunc) in Dulbecco’s modified Eagle medium (DMEM) with 10%
fetal calf serum (FCS). Unless otherwise indicated, cells were
transfected using Lipofectamine 2000 (Invitrogen), as described by
the manufacturer, and incubated at 37uC and 5% CO2 for at least
12–18 hours before imaging. For live cell experiments, the culture
medium was replaced with CO2-independent imaging medium.
Antibodies against mouse b-catenin (#610153) were purchased
from BD Biosciences, fluorescein-conjugated secondary antibodies
were from Jackson Immunoresearch, and nocodazole was
purchased from Sigma. PTP1B allosteric inhibitor 3-(3,5-Di-
bromo-4-hydroxy-benzoyl)-2-ethyl-benzofuran-6-sulfonicacid-(4-
(thiazol-2-ylsulfamyl)-phenyl)-amide (Cat #539741) was pur-
chased from Calbiochem.
Plasmid Constructs
PM-anchored PTP1B D/A was generated by inserting cDNA
encoding the catalytic domain of human PTP1B (residues 1–407)
flanked by Age I restriction sites into pRFP-tkB-C1 vector (gift of
Dr. M. Lackmann). pRFP-tkB-C1 (hereafter referred to as RFP-
TK) consists of the C-terminus membrane targeting domain and
part of linker domain of K(B)Ras downstream of mRFP.
Immuno-electron Microscopy
Cells were fixed with 4% paraformaldehyde in 0.2 M sodium
phosphate buffer, pH 7.4 for 5 min, followed by 2% paraformal-
dehyde in 0.1M sodium phosphate buffer for 30 min, then rinsed
with PBS and quenched with 50 mM glycine in PBS for 10 min.
After adding 2 ml of 1% gelatin, the cells were collected by
scraping the monolayer, centrifuged, resuspended in 10% gelatin
[56], and then centrifuged again for 1 min. After cooling on ice for
30 min, the pellet was cut into small cubes, which were infiltrated
with 2.3 M sucrose overnight, mounted on pins and frozen in
liquid nitrogen. Cryosections were prepared using an ultra-
cryomicrotome (Leica) and collected with a 1:1 solution of
2.3 M sucrose and 2% methyl cellulose [57]. Immunogold labeling
with anti-PTP1B (FG6) antibodies (diluted 1/10–1/50) was
performed and revealed with protein-A gold conjugate (Utrecht
University). Cryosections were viewed at 100kV on a Biotwin EM
scope (FEI) equipped with a SIS Keen View 1.361 K CCD
camera.
For cryo-electron microscopy of vitreous sections (CEMOVIS),
samples were treated as previously described [58]. Briefly, cells
were grown on ACLAR film (Science Services, Eppelheim,
Germany), fixed using HPM100 high pressure freezer (Leica
Microsystems, Germany) and cut at –150uC. Samples were
analyzed using a JEM-1400 electron microscope (JEOL Germany)
at 120 kV equipped with F-416 CCD camera (TVIPS, Gauting,
Figure 6. The ER is specifically polarized towards regions of cell-cell contact. (a) Cos-7 cells co-expressing PTP1B WT-mCitrine and RFP-TK
were treated with nocodazole (33 mM) and imaged for 40 min using TIRF microscopy. Two regions of interest ‘‘1’’ and ‘‘2’’ are highlighted in the
‘‘Merge’’ images and magnified in the far right panels. ‘‘1’’ shows a peripheral region of the cell with no cell-cell contact. The PM outline is traced in
white, the ER outline is traced in yellow, and ER retraction relative to the PM can be seen as an increase in distance between the two traced outlines
after 40 min of nocodazole treatment. ‘‘2’’ shows a region of cell-cell contact (indicated by arrows). Nocodazole treatment leads to ER retraction from
peripheral regions but not from areas of cell-cell contact. (b) MDCK cells expressing calreticulin-TFP, PTP1B D/A CD-mCitrine, and RFP-TK. On the right
hand side, a magnified region of interest (rectangle) shows peripheral regions of the ER. Lower left panel shows calculated concentration of PTP1B D/
A CD in a cell-cell contact region of interest based on fluorescence calibrated imaging [38]. Lower central panel: correlation of the average image
intensity measured in the cytoplasm of cells expressing mCitrine-PTP1B D/A CD to the absolute concentration, as determined from FCS
measurements. A linear fit (red line) yielded the calibration function used to calculate absolute concentrations from image intensities. Lower right
panel: Example of an auto-correlation G(t) curve of PTP1B D/A CD-mCitrine (black line) fit by a model accounting for anomalous diffusion and a triplet
term (red line). (c) MDCK cells co-expressing calreticulin-TFP and PTP1B D/A-RFP-TK were treated with nocodazole and imaged by confocal
microscopy for 40 min. ‘‘1’’ shows regions of cell-cell contact; note how the ER does not retract from these points after nocodazole treatment. ‘‘2’’
shows a peripheral region of the PM; note the distance increase between the ER and PM after nocodazole treatment. All scale bars correspond to
10 mm.
doi:10.1371/journal.pone.0036633.g006
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Pleasanton, CA) was used.
Confocal Imaging, Photoactivation and Time Lapse
Microscopy
Confocal imaging and photoactivation were performed using an
Olympus FlowView FV 1000 microscope with a 636/1.4 N.A oil
objective. Experiments were performed in an environmental box
in which live cells were maintained at 37uC and 5% CO2.
Photoactivation was performed in the region of interest using a
413 nm laser in the region of interest, and continued imaging of
the photoactivated pool was performed using a 488 nm laser. All
studies were conducted on randomly growing cells.
For confocal time-lapse microscopy, Cos-7 cells were transiently
co-transfected with EGFR-GFP and PTP1B-dHcRed using
Fugene 6 (Roche Biochemicals). Cells were serum-starved,
stimulated with EGF (100 ng/ml) and then subjected to confocal
time-lapse imaging. Images were captured using a confocal laser
microscope (Leica TCS-SP5) with a 636/1.4 N.A oil objective at
12-bit resolution. Image processing and quantitative analysis were
Figure 7. PTP1B accesses specific substrates at cell-cell contacts. (a, b) Cos-7 cells co-expressing EphA2-mCherry (panels ii, v) and dSH2-YFP
(panels iii, vi) were incubated for 1 hour at 37uC with PTP1B allosteric inhibitor (539741 PTP1B inhibitor, 250 mM), and monitored by confocal time
lapse microscopy. Transmission images (panel i) show the cell confluency and help to define regions of cell-cell contact. Intensity merge images
(panel iv, vii) showing the spatial localization of EphA2 (red) an dSH2 (green) before (iv) and after (vii) PTP1B inhibitor treatment. Note the markedly
increased co-localization (orange) at regions of cell-cell contact after inhibitor treatment, indicating increased EphA2 phosphorylation specifically in
this region. Scale bars correspond to 20 mm.
doi:10.1371/journal.pone.0036633.g007
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converted to 32-bit (floating point) format and thresholded.
Background was defined as not a number (nan) and ratio images
were then generated by dividing PTP1B D/A dHcRed by EGFR-
GFP images.
Fluorescence Recovery after Photobleaching
Photobleaching was performed on the temperature-controlled
stage of a Leica SP2 AOBS Sirius microscope equipped with a
636/1.4 N.A oil immersion lens. GFP was excited using a 488 nm
Argon laser, and fluorescence was monitored at 0.203 sec
intervals. Fifty pre-bleach images were recorded with 4% laser
power of the 488 line every 0.203 sec. Consequently, a region of
interest (outlined in the figure) was photobleached using 100%
laser power of the 456, 476, 488 and 496 lines. Recovery of
fluorescence was monitored over the course of 300 whole-cell
scans (with a scan interval of 0.203 sec).
For bleaching of PTP1B WT-GFP and PTP1B D/A-GFP in the
ER, a circular region of 4 mm diameter was used, whereas for
bleaching at cell-cell contacts, we used a rectangular area of 5 mm
length and 1 mm width. Cells with varying levels of transfection
ranging from high to low PTP1B WT and D/A expression were
studied. Mean fluorescence intensities in the FRAP region and for
the whole cell (including the FRAP region) were recorded, and the
background was subtracted. The FRAP region and whole cell
profiles were then individually normalized to their pre-bleach
values (obtained by averaging the 11 images immediately
preceding bleaching), and the final FRAP recovery profile was
obtained by dividing the normalized FRAP region intensity by the
normalized whole cell intensity. This final step removed the global
fluorescence decrease due to photobleaching during initial
bleaching (,5% for FRAP experiments in the ER and 5–20%
for FRAP experiments in the cell-cell contacts), as well as any
gradual bleaching occurring during acquisition of the recovery
(less than a few percent for all experiments). Mathematical
modeling was used to fit the recoveries (see Supplementary
Materials).
Total Internal Reflection Fluorescence Microscopy
Cos-7 cells were transiently co-transfected with RFP-TK and
PTP1B WT-mCitrine or PTP1B D/A-mCitrine using Effectene
(Qiagen). Cells were plated onto glass-bottom 35 mm dishes
(MatTek) and then were incubated in CO2-independent medium
supplemented with 10% FCS and 2.5 mM L-glutamine. Images
were acquired with an inverted Olympus Cell ˆR microscope
configured for triple line total internal reflection fluorescence,
using a 606 PLAPO/TIRFM-SP oil immersion objective, with
1.45 N.A at 16-bit resolution in each channel.
Fluorescence Calibrated Confocal Time-lapse Microscopy
Fluorescence-calibrated time lapse imaging was performed on a
Zeiss LSM 510 Meta confocal microscope equipped with a
ConfoCor 3 unit and a C-Apochromat 406/1.2 N.A water
immersion objective. Experiments were performed in an environ-
mental box in which the sample and objectives were maintained at
37uC. mTFP and mCitrine were excited with 458 nm and 514 nm
argon lasers, respectively, whereas RFP was excited with a
561 DPSS laser. The fluorescent light was passed through a
NFT 565 beam splitter and detected with PMT detectors through
a BP 475–525 band pass filter for mTFP, a LP 530 long pass filter
for mCitrine, and a LP 575 long pass filter for RFP. To minimize
cross-talk between individual channels, mTFP and RFP were
recorded simultaneously, whereas mCitrine was imaged separate-
ly. Pinhole diameter was set to 192 mm for mTFP, 296 mm for
RFP, and 1000 mm for mCitrine. Images were recorded at a
resolution of 5126512 pixels (0.15 mm/pixel) and a bit depth of
12 bit. For time-lapse imaging, single-plane multi-color images
were recorded at 1 minute intervals.
To correlate the image intensity of mCitrine to absolute protein
concentrations, we acquired single-channel images of cells
expressing mCitrine-PTP1B D/A CD at exactly the same settings
as for the time-lapse experiments. Fluorescence correlation
spectroscopy (FCS) measurements were performed at randomly
chosen positions in the cytoplasm of the same cells. Background-
corrected average image intensities were determined in a 1 mm
radius around the FCS measurement point. For FCS, mCitrine
was excited with the 514 nm line of an argon laser, while an APD
detector recorded the fluorescence through a LP 530 long pass
filter and a 70 mm pinhole. The raw intensity data were correlated
using the microscope manufacturer’s software, and for each
measurement, correlation curves were averaged for ten consecu-
tive 10-second intensity recordings. Averaged correlation curves
were fit by using a model accounting for anomalous diffusion and
a triplet term in order to determine the average number of
particles in the confocal observation volume, using a non-linear
least squares minimization algorithm implemented in Matlab
(MathWorks). Confocal volume was determined from calibration
measurements of an Alexa 546 dye solution, assuming a diffusion
coefficient of 280 mm
2/s at 25uC that was extrapolated to
308 mm
2/s at 37uC.
Mathematical Model for Fitting FRAP Data
For the circular FRAP in the ER (PTP1B WT and PTP1B D/
A), we used the analytic formula for a cylindrical region in an
infinite medium [59]:
f(t)~exp({2tD=t) I0(2tD=t)zI1(2tD=t) ½  , ð1Þ
wheref(t) denotes the FRAP recovery (recovering from 0 to 1),
I0(x) and I1(x) are the standard modified Bessel functions, and
tD~r2 
4D is the diffusion timescale with r the radius of the FRAP
region and D the diffusion constant. Considering the case of
imperfect bleaching and the possibility of an incomplete recovery
due to an immobile fraction leads to the following formula:
f(t)~(1{g)eexp({2tD=t) I0(2tD=t)zI1(2tD=t) ½  z(1{e), ð2Þ
where0ƒeƒ1 is the bleaching efficiency (with e~1 corresponding
to complete bleaching) and 0ƒgƒ1 is the immobile fraction. The
initial FRAP bleaching in the region of interest in our cells
removed less than a few percent of the total cellular fluorescence.
This justifies the use of the ‘‘infinite cell’’ approximation implicit in
Eq. 2.
We obtained the following values for diffusion constants and
immobile fractions for the four intracellular/ER FRAP data sets
(taking r~2 mm for the radius of the FRAP region):
D( mm2 s
21) g n
PTP1B WT-GFP 0:23+0:01 0:12+0:02 11
PTP1B D/A-GFP 0:070+0:003 0:28+0:02 13
TCPTP-GFP 0:20+0:01 0:04+0:03 12
SHP2-GFP 1:0+0:10 :04+0:03 9
Each FRAP profile was fit independently, and the above values
quoted are the mean and standard error of mean (S.E.M) for the
indicated number of cells, n (individual cell profiles shown in Fig.
S2). The mean and S.E.M of the diffusion constant were based on
the statistics of the logarithm oftD: The above parameters also fit
well the mean cell profile obtained by simply averaging all of the
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D/A, therefore, has a three-fold lower diffusion constant and a
two-fold greater immobile fraction than PTP1B WT, consistent
with the ‘‘trapping’’ nature of its catalytic region mutation. The
diffusion of PTP1B WT is similar to that of another ER-bound
phosphatase, TCPTP; however, the immobile fraction of TCPTP
is insignificant (consistent with the few percent removal of
fluorescence from the initial FRAP bleaching). All of the ER-
bound proteins diffuse much more slowly than the cytosolic SHP2
(which also has an insignificant immobile fraction).
For the FRAP experiments at the cell-cell interface, we
employed a Laplace transform approach similar to that used
previously [60,61]. In the latter, a 2D cylindrically-symmetric
geometry was explored. Here, we have a 1D system with a non-
trivial boundary condition (due to the location of the binding sites
there). Because this important case was not examined before and,
in particular, because the inclusion of boundary conditions is
subtle, we provide a full derivation for the sake of clarity and
completeness. The following equations describe the concentration
of a freely diffusing fluorescent protein, F(x,t); free binding sites,
B(x,t); and binding sites bound with the fluorescent protein,
C(x,t) :
LF(x,t)
Lt
~D+2F(x,t){konB(x,t)F(x,t)zkoffC(x,t) ð3Þ
LB(x,t)
Lt
~{konB(x,t)F(x,t)zkoffC(x,t) ð4Þ
LC(x,t)
Lt
~konB(x,t)F(x,t){koffC(x,t): ð5Þ
Because the binding sites are localized to the cell-cell interface,
B(x,t)~B(t)
V
A
d(x)~B(t)Ld(x) and, similarly,C(x,t)~C(t)Ld(x),
where A is area of the cell-cell interface (at x~0) and V~AL is
the cell volume. This gives:
LF(x,t)
Lt
~D+2F(x,t){konB(t)Ld(x)F(x,t)zkoffC(t)Ld(x) ð6Þ
dB(t)
dt
~{konB(t)F(0,t)zkoffC(t) ð7Þ
dC(t)
dt
~konB(t)F(0,t){koffC(t) ð8Þ
At steady state, the concentration of free binding sites, Beq, is
unaffected by the FRAP process. We therefore need consider only
the time dependence of F(x,t) and C(t): Following bleaching, the
free and bound fluorescent protein concentrations split into bright
and dark fractions:
F(x,t)~Fb(x,t)zFd(x,t) ð9Þ
C(t)~Cb(t)zCd(t) ð10Þ
Upon substituting back into the differential equations above,
these equations can be dissected into separate sets of equations (of
the same form) for both the bright and dark fractions. Of course,
we are only able to monitor the bright fraction:
LFb(x,t)
Lt
~D+2Fb(x,t){konBeqLd(x)Fb(x,t)z
koffCb(t)Ld(x)
ð11Þ
dCb(t)
dt
~konBeqFb(0,t){koffCb(t) ð12Þ
These equations are best solved by the Laplace transform,
which gives:
p  F Fb(x,p){Fb(x,0)~
D+2  F Fb(x,p){konBeqLd(x)  F Fb(x,p)zkoff   C Cb(p)Ld(x)
ð13Þ
p  C Cb(p){Cb(0)~konBeq  F Fb(0,p){koff   C Cb(p), ð14Þ
where the bar indicates the Laplace-transformed function depen-
dent on the Laplace transform variable p. Rearranging,
D+2Fb x,p ðÞ { pzkonBeqLd x ðÞ
  
Fb x,p ðÞ z
koffCb p ðÞ Ld x ðÞ ~{Fb x,0 ðÞ
ð15Þ
  C Cb(p)~
konBeq  F Fb(0,p)zCb(0)
pzkoff
ð16Þ
The initial concentration of the free protein is justFb(x,0)~Feq:
We assume an initial bleaching of the bound protein,
givingCb(0)~ 1{e ðÞ
konBeq
koff
Feq, where 0ƒeƒ1 is the bleaching
efficiency, with e~1 denoting complete bleaching. Substituting
  C Cb(p) into the differential equation for   F Fb(x,p) now gives:
D+2Fb x,p ðÞ { pzkonBeqLd x ðÞ
  
Fb x,p ðÞ z
konBeqLd x ðÞ
koffF 0,p ðÞ z 1{e ðÞ Feq
pzkoff
~{Feq
ð17Þ
For xw0,
D+2  F Fb(x,p){p  F Fb(x,p)~{Feq, ð18Þ
with general solution:
  F Fb(x,p)~A(p)cosh
ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
p=D
p
x
  
zB(p)sinh
ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
p=D
p
x
  
zFeq
 
p: ð19Þ
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L  F Fb
Lx
       
x~0
~
konBeq
pzkoff
L
D
p  F Fb(0,p){ 1{e ðÞ Feq
  
ð20Þ
and at x~L is simply 0 (hard wall, Neumann boundary
condition). Using the boundary conditions to solve for the
coefficients of the general solution yields:
L  F Fb
Lx
       
x~0
~B(p)
ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
p=D
p
~
konBeq
pzkoff
L
D
pA(p)zeFeq
  
ð21Þ
L  F Fb
Lx
       
x~L
~A(p)
ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
p=D
p
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p=D
p
L
  
z
B(p)
ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
p=D
p
cosh
ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
p=D
p
L
  
~0:
ð22Þ
These give the following for the specific solution (atx~0):
  F Fb(0,p)~
Feq
p
1{
e
1z 1z
p
koff
  
koff
konBfree
ﬃﬃﬃﬃﬃﬃﬃﬃ
D
pL2
r
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pL2
D
r  !
0
B B B B @
1
C C C C A
:
ð23Þ
This can then be substituted into the equation for   C Cb(p),
yielding
  C Cb(p)~
konBeq
koff
Feq
1
p
1
1z
p
koff
1{
e
1z 1z
p
koff
  
koff
konBeq
ﬃﬃﬃﬃﬃﬃﬃﬃ
D
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r
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ﬃﬃﬃﬃﬃﬃﬃﬃ
pL2
D
r  ! z 1{e ðÞ
p
koff
0
B B B B @
1
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:
ð24Þ
Normalizing to the pre-bleach amount of bound protein and
rearranging gives the following dimensionless form for the Laplace
transform of the recovery of fluorescence at the cell-cell interface:
  f f(p)~
  C Cb(p)
konBeq
koff
Feq
~
1
p
{e
1
koff
1
1z
p
koff
z
1
p
1
1z
p
koff
1
1z 1z
p
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1
b
ﬃﬃﬃﬃﬃﬃﬃﬃ
1
ptD
r
tanh
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ptD
p   
0
B B B @
1
C C C A
,
ð25Þ
where tD~
L2
D
is the diffusion timescale and b~
konBeq
koff
is the
contrast, which is equal to the ratio of the total protein bound at
the interface (x~0) to the total free protein in the cell. The full
recovery is then:
f (t)~InvLap(  f f(p),t) ð26Þ
f(t)~1{e e
-kofftzInvLap(  g g(p),t)
  
ð27Þ
with
  g g(p)~
1
p
1
1z
p
koff
1
1z 1z
p
koff
  
1
b
ﬃﬃﬃﬃﬃﬃﬃﬃ
1
ptD
r
tanh
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ptD
p   
: ð28Þ
From the fitting, we find that the ‘‘tanh’’ term is effectively 1 in our
case, implying:
  g g(p)&
1
p
1
1z
p
koff
1
1z 1z
p
koff
   ﬃﬃﬃﬃ
L
p
r , ð29Þ
with the recovery effectively depending on only two unknown
parameters: koff and L~ 1
b2tD
(the contrast and diffusion timescale
are degenerate). But this is just the recovery one gets assuming an
‘‘infinite’’ cell. Here, the general solution is just:
  F Fb(x,p)~U(p)exp {
ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
p=D
p
x
  
zFeq
 
p: ð30Þ
The boundary condition at x~0 (using Gauss’s law) is
L  F Fb
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x~0
~
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giving:
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And, again,
f(t)~1{e e
-kofftzInvLap(  g g(p),t)
  
ð36Þ
now with the exact equality:
  g g(p)~
1
p
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r : ð37Þ
The recovery (normalized only to the pre-bleach fluorescence in
the FRAP region) asymptotically approaches the following value:
lim
t??
f(t)?1{e
b
bz1
, ð38Þ
which for complete initial bleaching of the bound protein (e~1) is
just
1
bz1
, or the ratio of free protein to total protein. However, for
our data analysis, we additionally normalized to the total cellular
fluorescence at each time point:
fnorm(t)~
1zb
1z 1{e ðÞ b
f(t), ð39Þ
which removes the reduction in intensity caused by the bleaching
of the total cellular fluorescence. The bleaching efficiency is
directly observed, and the diffusion constant can be obtained by
FRAP in the interior of the cell (hence, our FRAP experiments
with PTP1B D/A in the ER, which yielded D~0:070 mm2 s21).
Assuming that the confocal plane we observe is representative, we
find that b&0:1 for most cells (this value, true for the entire stripe,
can also be used for our experiments wherein only one third of the
interface was bleached). This implies that the additional normal-
ization in fnorm(t) is only a few percent. It is therefore safe to
ignore this (the ‘‘b is small’’ limit wherefnorm(t)&f(t)) and simply
fit tof(t):
Assuming zero immobile fraction (see below), we have
independently fit the recovery curve for each of the 12 cells (Fig.
S2), obtaining mean and S.E.M values (based on the logarithmic
values) for the two remaining free parameters
koff§0:085+0:006 s
21 (residence half-life of t1=2ƒ8:2 s) and
L~0:0088+0:0011 s
21. For most of the recovery curves, koff
needed only to be greater than some minimal value in order to fit
the data, hence the lower limit. The mean values again fit well the
mean profile resulting from averaging the recovery profiles of all of
the cells, as shown in Fig. 4b. Using L~0:0088 s
21,
D~0:070 mm
2 s
21, andb&0:1, gives an effective cell length
of L~
1
b
ﬃﬃﬃﬃ
D
L
r
&28 mm, which is comparable to the observed cell
sizes. The FRAP recovery of PTP1B D/A at the cell-cell interface is
therefore consistent with rapid turnover (t1=2ƒ8:2 s), the ER-
determined diffusion constant, the observed level of PTP1B D/A
accumulation at the interface, and the cell size. From the raw
images themselves (Fig. 4a), it is already clear that the recovery we
observe is not an artifact, but represents a real turnover of bound
protein at the cell-cell interface. As mentioned above, an immobile
fraction at the cell-cell interface is not required in order to fit the
recovery (in all of our displayed fits, we assume no immobile
fraction). Recoveries assuming an immobile fraction also fit the data
(not shown), and on a cell-by-cell basis these fits provide a useful
upper limit to the immobile fraction at the cell-cell interface ranging
from ,30% to ,70%. Theoretically, a longer acquisition time
would help eliminate most of the parameter degeneracy and place a
tighter limit on the immobile fraction, but observation of the actual
long-term recovery is severely complicated by cell movement and
morphological changes occurring on minute timescales.
All of the analysis was performed in Mathematica (Mathema-
tica, Inc.), where we have used the inverse Laplace transform
algorithms described in: http://library.wolfram.com/infocenter/
MathSource/4738/and http://library.wolfram.com/infocenter/
MathSource/5026/.
Supporting Information
Figure S1 PTP1B D/A on the surface of the ER accesses
PM substrates at points of cell-cell contact. (a) Serial
images were acquired at successive focal planes of PTP1B-null
fibroblasts expressing PTP1B D/A-GFP (Z step: 0.23 mm).
Regions of cell-cell contact are indicated with arrows and
magnified in the inset. Note the ‘‘honeycomb’’ appearance
characteristic of the ER. (b) Cells expressing PTP1B WT or D/
A were treated with the general tyrosine phosphatase inhibitor
pervanadate to disrupt PTP-substrate interactions. Note the
disappearance of PTP1B D/A localization at points of cell-cell
contact after pervanadate treatment, indicating interaction of
PTP1B D/A with PM bound substrates. Areas of cell-cell contact
are indicated with an arrow. Scale bars correspond to 5 mm.
(TIF)
Figure S2 The ER also lies in proximity to the PM in
HeLa cells. Epon section routine EM and high-resolution cryo-
electron microscopy of vitreous sections (CEMOVIS) of wild type
HeLa cells showing close association of ER and PM membranes
(arrows). ER: endoplasmic reticulum; PM: plasma membranes of
neighboring cells; asterisks: tight junctions; scale bar 100 nm.
(TIF)
Figure S3 Quantitative assessment of fluorescence
recovery in cells expressing various PTPs. Assessment of
fluorescence recovery over time of various PTPs at the ER (a-d)o r
PTP1B D/A at regions of cell-cell contact (e) in different cells. The
fitted model curves (red) are overlaid on the experimental data
(black). (f) FRAP recovery rates of PTP1B D/A at regions of cell-
cell contact in cells with different levels of PTP1B D/A
accumulation. The curves correspond to different ratios of total
bound to total free PTP1B D/A in the cell, which is designated as
b in the model (curve labels specify the values for b that were
used). The central curve (b~0:1) is identical to the averaged
PTP1B D/A cell-cell recovery model shown in Fig. 4b. A larger
accumulation at regions of cell-cell contact clearly leads to a slower
recovery. Because the level of accumulation and cell length are
degenerate in the model, the exact same curves would also result
by varying the cell length by similar factors.
(TIF)
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PLoS ONE | www.plosone.org 16 May 2012 | Volume 7 | Issue 5 | e36633Figure S4 Polarity of the ER. (a) Cos-7 cells co-expressing
Calreticulin-TFP and RFP-TK were treated with nocodazole
(33 mM) and imaged for 30 min using TIRF microscopy. Two
regions of interest ‘‘1’’ and ‘‘2’’ are highlighted and magnified in
the ‘‘Merge’’ images. ‘‘1’’ shows a peripheral region of PM with no
cell-cell contact; note how the ER extends out to the peripheral
PM before treatment. ‘‘2’’ shows a region of cell-cell contact
(indicated by yellow arrow); note that the ER does not retract from
points of cell-cell contact after treatment. (b) Cos-7 cells co-
expressing PTP1B D/A and RFP-TK were treated with
nocodazole and imaged for 40 min using TIRF microscopy. In
the lower right panel, arrows indicate the long stretches of ER
network that remain attached to sites of adhesion to the glass
coverslip following nocodazole treatment; this is observed only for
cells overexpressing PTP1B D/A. Scale bars correspond to 10 mm.
(TIF)
Figure S5 PTP1B WT localization is not altered by
PTP1B D/A co-expression. Randomly growing MDCK cells
were transiently co-transfected with PTP1B WT-mCitrine and
PTP1B D/A-mCherry. PTP1B WT and PTP1B D/A colocalized
across the entire ER; however, the D/A mutant was clearly much
more highly accumulated to cell-cell contact sites. Right panel
represents phase contrast images of the cells and arrows indicate
sites of cell-cell contact.
(TIF)
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